Project Grant RF1NS144225
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of Columbia University in the City of New York a $6.0 million Project Grant on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the causal relationship between fine particulate matter (PM2.5) components and Lewy body dementia (LBD). The four-year research initiative (through July 31,...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $418,000 Project Grant to Harvard T.H. Chan School of Public Health, effective August 1, 2025, through July 31, 2027, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award funds a comprehensive investigation examining the potential role of viral and bacterial infections in the development of Parkinson's disease...
- Federal Project Grant Award Summary Brigham & Women's Hospital Inc., through its Department of Faulkner Pathology in Boston, Massachusetts, received a $557,883 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award was obligated on May 1, 2026, with a completion date of April 30, 2031. This five-year research initiative investigates the...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant totaling $122,526 to The Leland Stanford Junior University on May 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This research initiative, scheduled for completion by April 30, 2028, focuses on delineating Alzheimer's Disease (AD) initiation and propagation mechanisms using novel adult human...
- Federal Project Grant Award Summary Harvard Medical School received a $1.2 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2033. The award funds an eight-year basic neuroscience research initiative investigating cerebellar circuit organization and function. The research will employ intersectional...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Broad Institute of MIT and Harvard a $481,250 Project Grant on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports a two-year research initiative concluding July 31, 2027, focused on advancing prion disease treatment through deep prion protein (PrP) suppression. The project will deliver...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $460,625 to the University of Massachusetts Medical School on June 7, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This exploratory research project, scheduled for completion by May 31, 2027, investigates the roles of the deubiquitylation pathway in TDP-43 (TAR DNA-binding protein 43) pathology relevant to...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Louisiana State University Health Sciences Center-Shreveport $582,172 on May 13, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This Project Grant funds a mechanistic investigation into the chronic neuropathologic interaction between viral infection and the progression of Lewy pathology and dementia. The research will...
- Federal Grant Award Summary Virginia Commonwealth University received a $1.37 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded June 20, 2025, with a completion date of March 31, 2030. The grant supports research to elucidate the role of cholinergic degeneration in cognitive fluctuations (CF) associated with Lewy body dementia (LBD)....
- Federal Project Grant Award Summary Harvard College, through its Office for Sponsored Programs Division, received a $120,582 Project Grant award on January 17, 2026, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The research is scheduled for completion by December 31, 2027, and will be conducted at Harvard's Cambridge, Massachusetts facility. The award supports...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $1,766,366 to Harvard T.H. Chan School of Public Health, with an award date of May 6, 2026 and completion date of April 30, 2029. Under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), the awardee will conduct research investigating the impact of environmental factors on Lewy Body Dementia (LBD), a neurodegenerative disorder affecting over one million Americans. The research will produce rigorous, evidence-based identification of modifiable environmental factors that contribute to LBD exacerbation and characterization of vulnerable subpopulations at higher risk. The project will deliver research outputs through two complementary approaches: epidemiological analysis leveraging nationwide Medicare claims data (including over 550,000 LBD hospitalizations from 2000-2020) linked to environmental exposure data such as air pollutants (PM2.5, nitrogen dioxide, ozone), pesticide exposure, and weather variables; and mechanistic studies using an in vitro LBD model system to evaluate disease susceptibility to environmental factors. This integrated methodology combining advanced causal inference statistical methods with laboratory-based mechanistic investigation will provide actionable insights into environmental contributions to LBD pathogenesis and identify high-risk populations for targeted interventions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.8m | 5/7/26 |